Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_581ae3a68286af10919b25930e1f2e34 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-48 |
filingDate |
2009-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28b7422696c0e0de92947f768a55e0fe |
publicationDate |
2010-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-201031415-A |
titleOfInvention |
Glycine tomentella Hayata inhibits IL-1 β, IL-6 and transglutaminase type 2 |
abstract |
The present invention provides a composition for inhibiting cytokine expression comprising organic extract from Glycine tomentella Hayata, wherein the cytokine is selected from the group consisting of interleukin-1 β (IL-1 β ), interleukin-6 (IL-6), transgluaminase type 2 (TG2) and matrix metalloproteinase 9 (MMP-9). |
priorityDate |
2009-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |